SCHEMBL5013092

SCHEMBL5013092

CN(Cc1ccccc1)c1nc2sc(C(N)=O)c(N)c2c2c1COC(C)(C)C2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.55
ATM Q13315 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
ALDH1A1 P00352 7/20 0.55
MAPT P10636 4/20 0.55
HPGD P15428 5/20 0.51
GAA P10253 3/20 0.51
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
HSD17B10 Q99714 2/20 0.49
POLB P06746 2/20 0.49
PKM P14618 1/20 0.49
ALOX15 P16050 1/20 0.49
CASP1 P29466 1/20 0.49
BLM P54132 1/20 0.49
CASP7 P55210 1/20 0.49
CACNA1B Q00975 1/20 0.49
APBA1 Q02410 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4048241 0.89 HTT (0.47) KDM4EATMTDP1ALDH1A1MAPT
SCHEMBL5015905 0.85 KDM4E (0.64) KDM4EATMTDP1ALDH1A1MAPT
SCHEMBL5013088 0.81 KDM4E (0.55) KDM4EATMTDP1ALDH1A1MAPT
SCHEMBL4708892 0.75 ALDH1A1 (0.68) KDM4EALDH1A1MAPTHPGDGAA
SCHEMBL5013112 0.75 KDM4E (0.47) KDM4ETDP1ALDH1A1HPGDKMT2A
SCHEMBL5054674 0.75 POLB (0.54) KDM4ETDP1ALDH1A1MAPTHPGD
SCHEMBL5013104 0.74 KDM4E (0.48) KDM4EATMTDP1ALDH1A1MAPT
SCHEMBL5013137 0.73 KDM4E (0.85) KDM4EATMTDP1ALDH1A1MAPT
SCHEMBL4049074 0.73 CDK8 (0.50) KDM4EATMTDP1ALDH1A1MAPT
SCHEMBL5014738 0.72 KDM4E (0.83) KDM4EATMTDP1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207645-A1 Pyridothienopyrimidine Derivatives PAGES SANTACANA LUIS MIGUEL 2008-08-28 US disclosed
EP-1819712-A1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES Laboratorios Almirall, S.A. (ES) 2007-08-22 EP disclosed
WO-2006058723-A1 NEW PYRIDOTHIENOPYRIMIDINE DERIVATIVES LABORATORIOS ALMIRALL, S.A. (ES) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207645-A1 Pyridothienopyrimidine Derivatives PDE4A, PDE5A, PDE3B KDM4E 1526/4885ATM 2846/4885TDP1 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.